| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase | 8358 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8363 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8370 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8371 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8373 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8376 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8378 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8379 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8385 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8390 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8392 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8393 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8399 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8403 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8404 | Group:FD | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8356 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8382 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8387 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8391 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8394 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8396 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8405 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8407 | Group:FH | Gender:F | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8359 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8360 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8367 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8368 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8372 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8374 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8375 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8377 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8380 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8383 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8384 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8395 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8397 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8400 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8402 | Group:MD | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8355 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8362 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8364 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8366 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8381 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8386 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8389 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8398 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8401 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8406 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8408 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8409 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
| Reversed phase | 8410 | Group:MH | Gender:M | mg/kg (relative quantification, NOT ABSOLUTE) |
Return to study ST001052 main page
Download data matrix(Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-I) Reversed phase)
- Metabolomics Workbench
|